CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
36.99
-1.05 (-2.76%)
At close: Mar 28, 2025, 4:00 PM
35.44
-1.55 (-4.19%)
Pre-market: Mar 31, 2025, 8:53 AM EDT

CRISPR Therapeutics AG Market Cap

CRISPR Therapeutics AG has a market cap or net worth of $3.17 billion as of March 31, 2025. Its market cap has decreased by -47.15% in one year.

Market Cap
3.17B
Enterprise Value
1.49B
1-Year Change
-47.15%
Ranking
Category
Stock Price
$36.99

Market Cap Chart

Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $3.17B, an increase of 466.47%. That is a compound annual growth rate of 22.80%.

History

DateMarket Cap% Change
Mar 28, 20253.17B-5.56%
Dec 31, 20243.36B-32.44%
Dec 29, 20234.97B56.24%
Dec 30, 20223.18B-45.12%
Dec 31, 20215.80B-46.39%
Dec 31, 202010.82B221.74%
Dec 31, 20193.36B126.76%
Dec 31, 20181.48B53.95%
Dec 29, 2017963.10M19.42%
Dec 30, 2016806.50M43.99%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings